Versor Investments LP bought a new position in shares of The Clorox Company (NYSE:CLX - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 4,700 shares of the company's stock, valued at approximately $763,000.
Several other hedge funds and other institutional investors have also recently bought and sold shares of CLX. Brooklyn Investment Group grew its stake in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after purchasing an additional 95 shares during the last quarter. Prospera Private Wealth LLC acquired a new position in Clorox in the third quarter worth approximately $27,000. Continuum Advisory LLC increased its holdings in shares of Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company's stock valued at $30,000 after buying an additional 138 shares in the last quarter. Asset Planning Inc acquired a new stake in shares of Clorox during the 4th quarter valued at $32,000. Finally, BankPlus Trust Department bought a new stake in shares of Clorox during the 4th quarter worth $40,000. 78.53% of the stock is currently owned by institutional investors.
Clorox Stock Down 2.1 %
NYSE CLX traded down $3.28 on Tuesday, reaching $152.61. The stock had a trading volume of 1,325,842 shares, compared to its average volume of 1,381,572. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The business has a 50 day moving average price of $156.73 and a 200 day moving average price of $160.44. The company has a market capitalization of $18.80 billion, a price-to-earnings ratio of 41.63, a P/E/G ratio of 2.62 and a beta of 0.42.
Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the business posted $2.16 earnings per share. On average, analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.
Clorox Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.20%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox's payout ratio is presently 133.33%.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently issued reports on the company. Evercore ISI boosted their target price on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. DA Davidson cut their price objective on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a report on Wednesday, February 5th. StockNews.com cut shares of Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Royal Bank of Canada restated a "sector perform" rating and set a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. Finally, Wells Fargo & Company raised their price objective on shares of Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 4th. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $159.62.
Get Our Latest Report on Clorox
Clorox Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories

Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.